Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yuyang Ze"'
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Liver dysfunction is a common complication of Graves’ disease (GD) that may be caused by excessive thyroid hormone (TH) or anti-thyroid drugs (ATDs). Radioactive iodine (RAI) therapy is one of the first-line treatments for GD, but it is un
Externí odkaz:
https://doaj.org/article/21ec16a1e39649489025c8c5b88e36a2
Autor:
Xiaowen Zhang, Yuyang Ze, Jianfeng Sang, Xianbiao Shi, Yan Bi, Shanmei Shen, Xinlin Zhang, Dalong Zhu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Thyroid nodules (TNs) represent a common scenario. More accurate pre-operative diagnosis of malignancy has become an overriding concern. This study incorporated demographic, serological, ultrasound, and biopsy data and aimed to compare a new diagnost
Externí odkaz:
https://doaj.org/article/df9fea10735c494b83589d89260b66c8
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-14 (2018)
Abstract Background Efficacy trials showed that glucagon-like peptide–1 receptor (GLP1R) agonists reduced metabolic risk factors in addition to glucose lowering, but the cardiovascular and microvascular efficacy of this drug class remains to be det
Externí odkaz:
https://doaj.org/article/6b407a3e3c2e4a6e9e2674187a6d0ee1
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Malignant melanoma represents a particularly aggressive type of skin cancer, originating from the pathological transformation of melanocytes. While conventional interventions such as surgical resection, chemotherapy, and radiation therapy ar
Externí odkaz:
https://doaj.org/article/197d22cff5b7462dbe37b49666bd4faf
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-14 (2018)
Background Efficacy trials showed that glucagon-like peptide–1 receptor (GLP1R) agonists reduced metabolic risk factors in addition to glucose lowering, but the cardiovascular and microvascular efficacy of this drug class remains to be determined.
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract ZIF-8 may experience ion-responsive degradation in ionic solutions, which will change its initial architecture and restrict its direct biological use. Herein, we report an abnormal phenomenon in which ZIF-8 induces large hydroxyapatite-like
Externí odkaz:
https://doaj.org/article/7c4e905c27e740cc974af0256e1b234c
Publikováno v:
Journal of cancer research and clinical oncology. 145(11)
Papillary thyroid carcinoma (PTC), the most common malignant tumor of the thyroid, has been criticized as overtreated by some researchers in recent years. Active surveillance (AS) was first proposed at Kuma Hospital in 1993, and popularized in other
Autor:
Yiming Liu, Chun Ki Yiu, Zhao Zhao, Wooyoung Park, Rui Shi, Xingcan Huang, Yuyang Zeng, Kuan Wang, Tsz Hung Wong, Shengxin Jia, Jingkun Zhou, Zhan Gao, Ling Zhao, Kuanming Yao, Jian Li, Chuanlu Sha, Yuyu Gao, Guangyao Zhao, Ya Huang, Dengfeng Li, Qinglei Guo, Yuhang Li, Xinge Yu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Recent advances in virtual reality (VR) technologies accelerate the creation of a flawless 3D virtual world to provide frontier social platform for human. Equally important to traditional visual, auditory and tactile sensations, olfaction ex
Externí odkaz:
https://doaj.org/article/2505339f166a4ab8a078750eadf985f4
MOOSE checklist. (DOC 71 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b2d1df3b32fe281a4a3a712a7def09
Figure S1. Flow diagram of study selection; Table S1. Primary and secondary endpoints, inclusion and exclusion criteria of included randomized controlled trials; Table S2. Risk of bias of included randomized controlled trials; Figure S2. Trial sequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52301a969d7e3f19ca82e7ecda6748be